A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia
暂无分享,去创建一个
Sumio Watanabe | A. Nagahara | Kenshi Matsumoto | H. Ueyama | T. Takeda | Kohei Matsumoto | D. Asaoka | M. Hojo | Y. Shimada | Hitoshi Sasaki
[1] P. Moayyedi,et al. Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. , 2015, Gastroenterology.
[2] A. Pariente,et al. Why are benzodiazepines not yet controlled substances? , 2015, JAMA psychiatry.
[3] K. Sugano,et al. Evidence-based clinical practice guidelines for functional dyspepsia , 2015, Journal of Gastroenterology.
[4] B. C. Wong,et al. Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. , 2012, World journal of gastroenterology.
[5] J. Tack,et al. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] G. Boeckxstaens,et al. Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double‐blind placebo‐controlled study , 2011, Alimentary pharmacology & therapeutics.
[7] K. Tominaga,et al. Efficacy of the 5-HT1A Agonist Tandospirone Citrate in Improving Symptoms of Patients With Functional Dyspepsia: A Randomized Controlled Trial , 2009, The American Journal of Gastroenterology.
[8] P. Moayyedi,et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis , 2008, Gut.
[9] R. Laheij,et al. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[10] D. Drossman,et al. The functional gastrointestinal disorders and the Rome III process. , 1999, Gastroenterology.
[11] T. Ohkusa,et al. Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review , 2005, Journal of Gastroenterology.
[12] M. Otaka,et al. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline , 2005, Alimentary pharmacology & therapeutics.
[13] H. Seno,et al. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies , 2005, Alimentary pharmacology & therapeutics.
[14] Y. Kinoshita,et al. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia , 2005, Alimentary pharmacology & therapeutics.
[15] E. Deutsch. Relief of anxiety and related emotions in patients with gastrointestinal disorders , 1971, The American Journal of Digestive Diseases.
[16] F. Mearin,et al. Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[17] H. Parkman,et al. Effects of clonidine and tricyclic antidepressants on gastric smooth muscle contractility , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[18] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[19] Chi-Sen Chang,et al. Effect of fluoxetine on symptoms and gastric dysrhythmia in patients with functional dyspepsia. , 2003, Hepato-gastroenterology.
[20] Y. Kinoshita,et al. Prevalence of functional dyspepsia and its relationship with Helicobacter pylori infection in a Japanese population , 2001, Journal of gastroenterology and hepatology.
[21] V. Savarino,et al. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis , 2000, Alimentary pharmacology & therapeutics.
[22] S. Ishihara,et al. Prevalence of non‐ulcer dyspepsia in the Japanese population , 1999, Journal of gastroenterology and hepatology.
[23] J. Hyun,et al. Effects of Levosulpiride in Patients with Functional Dyspepsia Accompanied by Delayed Gastric Emptying , 1998, The Korean journal of internal medicine.
[24] K. Kroenke,et al. Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. , 1997, The American journal of medicine.
[25] D. Quaglino,et al. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial. , 1996, The Italian journal of gastroenterology.
[26] U. Malt,et al. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin. , 1996, Scandinavian journal of gastroenterology.
[27] Y. Saitoh,et al. Inhibitory effect of dopamine on gastric motility in rats. , 1995, Scandinavian journal of gastroenterology.
[28] L. Arendt-Nielsen,et al. The hypoalgesic effect of imipramine in different human experimental pain models , 1995, Pain.
[29] G. Corazza,et al. The eflects of levosulpiride on gastric and gall‐bladder emptying in functional dyspepsia , 1994, Alimentary pharmacology & therapeutics.
[30] M. Zompo,et al. A double‐blind study of L‐sulpiride versus amitriptyline in lithium‐maintained bipolar depressives , 1993, Acta psychiatrica Scandinavica.
[31] L. Balart,et al. Chlordiazepoxide-Clidinium Bromide in Gastrointestinal Disorders: Controlled Clinical Studies , 1968 .